Geode Capital Management, LLC Verve Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,600,687 shares of VERV stock, worth $7.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,600,687

Previous 1,559,772 2.62%

Holding current value

$7.28 Million

Previous $7.61 Million 1.79%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$4.4 - $7.86 $180,026 - $321,591	40,915 Added 2.62%	1,600,687 $7.75 Million
Q2 2024 Aug 09, 2024	BUY	$4.76 - $12.79 $525,246 - $1.41 Million	110,346 Added 7.61%	1,559,772 $7.61 Million
Q1 2024 May 13, 2024	BUY	$10.81 - $17.96 $3.45 Million - $5.73 Million	319,263 Added 28.25%	1,449,426 $19.2 Million
Q4 2023 Feb 13, 2024	BUY	$8.84 - $18.7 $683,181 - $1.45 Million	77,283 Added 7.34%	1,130,163 $15.8 Million
Q3 2023 Nov 13, 2023	BUY	$11.42 - $20.82 $1.1 Million - $2 Million	96,153 Added 10.05%	1,052,880 $14 Million
Q2 2023 Aug 11, 2023	BUY	$13.34 - $19.9 $946,553 - $1.41 Million	70,956 Added 8.01%	956,727 $17.9 Million
Q1 2023 May 15, 2023	BUY	$14.3 - $24.01 $543,943 - $913,292	38,038 Added 4.49%	885,771 $12.8 Million
Q4 2022 Feb 13, 2023	BUY	$17.85 - $40.7 $1.16 Million - $2.65 Million	65,021 Added 8.31%	847,733 $16.4 Million
Q3 2022 Nov 14, 2022	BUY	$15.63 - $41.49 $4.93 Million - $13.1 Million	315,492 Added 67.53%	782,712 $26.9 Million
Q2 2022 Aug 12, 2022	BUY	$11.14 - $23.17 $456,205 - $948,857	40,952 Added 9.61%	467,220 $7.14 Million
Q1 2022 May 13, 2022	BUY	$20.92 - $39.36 $2.84 Million - $5.35 Million	135,800 Added 46.75%	426,268 $9.73 Million
Q4 2021 Feb 11, 2022	BUY	$31.94 - $54.82 $500,308 - $858,700	15,664 Added 5.7%	290,468 $10.7 Million
Q3 2021 Nov 12, 2021	BUY	$46.0 - $73.99 $11.2 Million - $18 Million	242,702 Added 756.03%	274,804 $12.9 Million
Q2 2021 Aug 13, 2021	BUY	$31.92 - $60.25 $1.02 Million - $1.93 Million	32,102 New	32,102 $1.93 Million

Others Institutions Holding VERV

# of Institutions

186

Shares Held

73.3M

Call Options Held

85K

Put Options Held

215K

View Full List

About Verve Therapeutics, Inc.

Ticker VERV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,942,300
Market Cap $273M
Description
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...

More about VERV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Verve Therapeutics, Inc. Transaction History